August 25, 2015 9:48 AM | 1 min read |
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Analysts at Wunderlich initiated coverage on
Power Solutions International Inc (NASDAQ: PSIX) with a Buy rating. The target price for Power Solutions International is set to $50. Power Solutions International shares closed at $28.64 yesterday.Analysts at Baird initiated coverage on
MasTec, Inc. (NYSE: MTZ) with a Neutral rating. The target price for MasTec is set to $16. MasTec shares closed at $14.91 yesterday.Analysts at BTIG Research initiated coverage on
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) with a Buy rating. The target price for Synergy Pharmaceuticals is set to $11. Synergy Pharmaceuticals shares closed at $6.74 yesterday.Roth Capital initiated coverage on
Quantum Corp (NYSE: QTM) with a Buy rating. The target price for Quantum is set to $1.50. Quantum shares closed at $1.08 yesterday.Analysts at Maxim Group initiated coverage on
Access National Corporation (NASDAQ: ANCX) with a Buy rating. The target price for Access National is set to $21.50. Access National shares closed at $18.39 yesterday.Bank of America initiated coverage on
Compass Diversified Holdings (NYSE: CODI) with a Buy rating. The target price for Compass Diversified is set to $18. Compass Diversified shares closed at $15.87 yesterday.Analysts at Cowen & Company initiated coverage on
SolarCity Corp (NASDAQ: SCTY) with a Market Perform rating. The target price for SolarCity is set to $50. SolarCity shares closed at $43.87 yesterday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.